Skip to main content
SpringerLink
Log in

Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Regional cerebral blood flow was assessed in 19 patients with early idiopathic Parkinson's disease (PD) and 12 control subjects of similar age by single-photon emission tomography using technetium-99m hexamethylpropylene amine oxime (HMPAO). Of the patients with PD, seven were mildly demented and 15 presented with hemiparkinsonism. Mean HMPAO cortical or basal ganglia/cerebellum activity ratios were calculated. Mean cortical and regional uptake ratios in non-demented PD patients were not significantly different from values in the controls. In contrast, besides generalized cortical hypoperfusion, demented PD patients had significantly lower HMPAO uptake in the frontal and basal ganglia regions than non-demented patients. These observations support the hypothesis of impaired neuronal activity in both cortical and subcortical regions of the brain in demented PD patients. In hemiparkinsonian patients, the only asymmetrical finding was a relative hypoperfusion in the contralateral parietal region. This may be due to deafferentation of the thalamoparietal pathways. The lack of asymmetrical uptake in basal ganglia in our PD patients may be explained by their staging at the time of the investigation (stage I and II, Hoehn and Yahr scale).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Leenders KL, Wolfson L, Gibbs JM, Wise RJS, Causon R, Jones T, Legg NJ. The effects of l-dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. Brain 1985; 108:171–191.

    Google Scholar 

  2. Perlmutter JS, Raichle ME. Regional blood flow in hemiparkinsonism. Neurology 1985; 35:1127–1134.

    Google Scholar 

  3. Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1985; 135:1399–1405.

    Google Scholar 

  4. Melamed E, Lavy S, Cooper G, Bentin S. Regional cerebral blood flow in parkinsonism: measurement before and after levodopa. J Neurol Sci 1978; 38:391–397.

    Google Scholar 

  5. Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, Zanco P, Ferlin G, Battistin L. [99m-Tc]-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab 1988; 8 Suppl 1:S101-S108.

    Google Scholar 

  6. Spampinato U, Habert MO, Mas JL, Bourdel MC, Ziegler M, de Recondo J, Askienazy S, Rondot P. (99m-Tc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 1991;54:787–792.

    Google Scholar 

  7. Agniel A, Celsis P, Viallard G, Montastruc JL, Rascol O, Demonet JF, Marc-Vergnes JP, Rascol A. Cognition and cerebral blood flow in lateralized parkinsonism: lack of functional lateral asymmetries. J Neurol Neurosurg Psychiatry 1991; 54:783–786.

    Google Scholar 

  8. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NTS, Gvozdanovic D, Davidson J, Tyrrell DA, Pickett RD, Neirinckx RD. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986; 27:171–177.

    Google Scholar 

  9. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17:427–442.

    CAS  PubMed  Google Scholar 

  10. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189–198.

    Article  CAS  PubMed  Google Scholar 

  11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn, revised. Washington DC: APA; 1987;103–107.

    Google Scholar 

  12. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.

    Article  Google Scholar 

  13. Fahn S, Elton R, UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne CD, eds. Recent developments in Parkinson's disease, vol II. Florham Park, NJ: Macmillan; 1987:153–163.

    Google Scholar 

  14. Matsuda H, Oskoie SD, Kinuya K, Tsuji S, Sumiya H, Tonani N, Hisada K. Tc99m-HMPAO brain perfusion tomography atlas using a high resolution SPECT system. Clin Nucl Med 1990; 15:428–431.

    Google Scholar 

  15. Forno LS. Pathology of Parkinson's disease. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworths Scientific; 1982:25–40.

    Google Scholar 

  16. Montastruc JL, Celsis P, Agniel A, Demonet JF, Doyon B, Puel M, Marc-Vergnes JP, Rascol A. Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Mov Disord 1987; 2:279–289.

    Google Scholar 

  17. Lavy S, Melamed E, Cooper G, Bentin S, Rinot Y. Regional cerebral blood flow in patients with Parkinson's disease. Arch Neurol 1979; 36:344–348.

    Google Scholar 

  18. Melamed E, Mildworf B. Regional cerebral blood flow reductions in patients with Parkinson's disease: correlation with normal aging, cognitive functions, and dopaminergic mechanisms. In: Calne DB, et al., eds. Parkinsonism and aging. New York: Raven Press; 1989:221–228.

    Google Scholar 

  19. Whitehouse PJ, Hedreen JC, White III CL, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983; 13:243–248.

    Google Scholar 

  20. Johnson KA, Holman BL, Mueller SP, Rosen TJ, English R, Nagel JS, Growdon JH. Single photon emission computed tomography in Alzheimer's disease: abnormal iofetamine I-123 uptake reflects dementia severity. Arch Neurol 1988; 45:392–396.

    Google Scholar 

  21. Bes A, Guell A, Fabre N, Dupui P, Victor G, Geraud G. Cerebral blood flow studied by xenon-133 inhalation technique in parkinsonism: loss of hyperfrontal pattern. J Cereb Blood Flow Metab 1983; 3:33–37.

    Google Scholar 

  22. Lees AJ, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106:257–270.

    PubMed  Google Scholar 

  23. Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow. Brain 1986; 109:845–883.

    Google Scholar 

  24. Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y. A subcorticocortical cholinergic system is affected in Parkinson's disease. Brain Res 1983; 288:213–218.

    Article  PubMed  Google Scholar 

  25. Rinne JO, Lonnberg P, Marjamaki P, Rinne UK. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease. Brain Res 1989; 483:402–406.

    Google Scholar 

  26. Javoy-Agid F, Agid Y. Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology 1980; 30:1326–1330.

    Google Scholar 

  27. Mayeux R, Stern Y, Rosen J, Benson DF. Is “subcortical dementia” a recognizable clinical entity? Ann Neurol 1983 14:278–283.

    Google Scholar 

  28. Lenzi GL, Jones T, Reid JL, Moss S. Regional impairment of cerebral oxidative metabolism in Parkinson's disease. J Neurol Neurosurg Psychiatry 1979; 42:59–62.

    Google Scholar 

  29. Henriksen L, Boas J. Regional cerebral blood flow in hemiparkinsonian patients: emission computerized tomography of inhaled 133-xenon before and after levodopa. Acta Neurol Scand 1985; 71:257–266.

    Google Scholar 

  30. Masdeu JC, Van Heertum RL, Yudd A, Anselmi G. Single photon emission computed tomography findings in unilateral parkinsonism. J Neuroimag 1991; 1:200–202.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Neurological Institute, Veterans General Hospital-Taipei, 112, Taipei, Taiwan, Republic of China

    Shuu-Jiun Wang, Hsiu-Chih Liu, Ker-Neng Lin, Ding-E Shan, Kwan-Kum Liao, Jong-Ling Fuh & Liang-Shong Lee

  2. Department of Nuclear Medicine, Veterans General Hospital-Taipei, 112, Taipei, Taiwan, Republic of China

    Ren-Shyan Liu

  3. National Yang-Ming Medical College, 112, Taipei, Taiwan, Republic of China

    Shuu-Jiun Wang, Hsiu-Chih Liu, Kwan-Kum Liao, Jong-Ling Fuh & Liang-Shong Lee

Authors
  1. Shuu-Jiun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ren-Shyan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hsiu-Chih Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ker-Neng Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ding-E Shan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kwan-Kum Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jong-Ling Fuh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Liang-Shong Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Correspondence to: Hsiu-Chih Liu

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, SJ., Liu, RS., Liu, HC. et al. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization. Eur J Nucl Med 20, 339–344 (1993). https://doi.org/10.1007/BF00169811

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169811

Key words

Search

Navigation